Dyslipidemia is a classic risk factor for cardiovascular disease and is associatedwith VC.17,37 Inhibition of MR did not alter serum levels of lipid markersbut the influence of dyslipidemia in the progression of CC was confirmed. This evidence concerns the gene NR3C2 and cardiovascular disorder.